MCK241115C590000
- 37.95
- +12.89+51.44%
McKesson Newsroom
McKesson Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Here's Why McKesson (MCK) Is a Strong Momentum Stock
McKesson, Oracle, Thoma Bravo Among Finalists to Acquire Veradigm: Report
Barclays Maintains McKesson(MCK.US) With Buy Rating, Maintains Target Price $668
Express News | Mckesson Corp : UBS Raises Target Price to $708 From $590
Evercore Maintains McKesson(MCK.US) With Buy Rating, Maintains Target Price $680
A Quick Look at Today's Ratings for McKesson(MCK.US), With a Forecast Between $612 to $688
Analysts Offer Insights on Healthcare Companies: Aclaris Therapeutics (ACRS), McKesson (MCK) and Enhabit, Inc (EHAB)
Wall Street Closes At Record Highs After Reassurance From Powell: Magnificent 7 Hit $17 Trillion, Treasury Yields Erase Post-Election Spike
McKesson | 10-Q: Q2 2025 Earnings Report
Nasdaq 100 Extends Record Levels Ahead Of Fed Meeting, Tesla Hits 26-Month Highs, Small Caps Stall: What's Driving Markets Thursday?
McKesson Shares Jump After FY25 Outlook Boost, Strong 2Q Sales
Express News | Mckesson Shares up 10.5% After Co Raises Annual Profit Forecast
MCK Stock Gains as Q2 Earnings & Sales Top Estimates, '25 EPS View Up
HubSpot Posts Better-Than-Expected Results, Joins Under Armour, Lyft, Wolverine World Wide, Zillow And Other Big Stocks Moving Higher On Thursday
McKesson Up Over 8%, on Pace for Largest Percent Increase Since March 2020 -- Data Talk
Mizuho Adjusts Price Target on McKesson to $550 From $530, Maintains Neutral Rating
These Analysts Boost Their Forecasts On McKesson Following Upbeat Earnings
McKesson Is Maintained at Outperform by Evercore ISI Group
Sarepta Therapeutics To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Thursday